Publication | Open Access

Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer

Symptomatic Cardiac ToxicityEsophageal CancerHealth SciencesRadiation TherapyMedicine18F-fdg Pet DeterminationCardiovascular ToxicityOncologyRadiation OncologyCardiologyNuclear MedicineRadiologyCardiovascular Imaging